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Abstract
A critical step for avian influenza viruses to infect human hosts and cause epidemics or pandemics is acquisition of the
ability of the viral hemagglutinin (HA) to bind to human receptors. However, current global influenza surveillance does not
monitor HA binding specificity due to a lack of rapid and reliable assays. Here we report a computational method that uses
an effective scoring function to quantify HA-receptor binding activities with high accuracy and speed. Application of this
method reveals receptor specificity changes and its temporal relationship with antigenicity changes during the evolution of
human H3N2 viruses. The method predicts that two amino acid differences at 222 and 225 between HAs of A/Fujian/411/02
and A/Panama/2007/99 viruses account for their differences in binding to both avian and human receptors; this prediction
was verified experimentally. The new computational method could provide an urgently needed tool for rapid and large-
scale analysis of HA receptor specificities for global influenza surveillance.
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Introduction
The first critical step in influenza virus infection and transmission is
binding of the viral surface protein, hemagglutinin (HA), to receptors
on host cells. The ability of HA to bind terminal sialic acids that have
different linkages with the penultimate galactose unit determines
whether a virus can infect birds or humans or both (host tropism).
The natural hosts of influenza viruses are aquatic birds, which
predominantly express a2–3 sialylated glycans; an avian virus has to
gain the ability to bind human receptors, which are a2–6 sialylated
glycans, in order to cross the species barrier and infect humans
[1,2,3]. In recent years, the avian influenza virus H5N1 has been a
major public health concern because of its ability to cause a high rate
of mortality in infected individuals and an increasing incidence of
human infections. In the event that the H5N1 virus gains the ability to
bind well to human receptors, it might acquire the capacity for easy
human-to-human transmission and cause an influenza pandemic.
Knowing the receptor specificity of HA is also critical for the
timely production of influenza vaccines, because the most widely
used method for vaccine production requires growing human
influenza viruses in embryonated chicken eggs. If the HA of the
human virus does not bind well to receptors in chicken eggs,
vaccine production could be adversely affected. For example, the
World Health Organization (WHO) recommended the use of
influenza A/Fujian/411/02 (H3N2) virus for vaccine production
for the 2003–2004 flu season. However, the A/Fujian/411/02
virus failed to replicate well in chicken eggs [4,5], possibly due to
weak HA binding to sialic acid receptors in the allantoic and
amniotic cavities. As a result, an earlier H3N2 strain of A/
Panama/2007/99 had to be used in its place for vaccine
production. The antigenic difference between the two strains
was so large that immunity induced by A/Panama/2007/99 did
not protect against infection by the Fujian-like viruses, rendering
the vaccine ineffective during the 2003–2004 flu season [6,7].
Using reverse genetics technology, it has been shown that two
amino acid changes of either G186V and V226I, or H183L and
V226A are sufficient for the Fujian virus to adapt for growth in
eggs [4]. Differences in amino acids at positions 155 and 156
account for the antigenic differences between the Panama and
Fujian viruses [5]. Despite these progresses, little is known about
the molecular basis for the altered receptor binding specificity in
the evolution of Fujian-like viruses from the A/Panama/2007/99
virus, or the evolutionary relationship between changes in
antigenicity and receptor binding specificity.
Given that the receptor binding specificity of HA directly affects
influenza transmission from avian species to humans, it is
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18664
imperative to develop robust and effective methods for monitoring
changes in the receptor binding specificity of influenza viruses as
they evolve. Major efforts have been devoted to understand the
molecular mechanisms governing HA binding specificities by
determining crystal structures of HA-receptor complexes and
analyzing HA-glycan binding using glycan arrays
[8,9,10,11,12,13,14,15,16,17]. Computational models have also
been developed to assess HA-receptor binding on a small scale.
Several studies have used the ab initio fragment molecular orbital
method, in conjunction with molecular dynamics and molecular
mechanics approaches, to calculate HA-receptor binding activity
[18,19,20,21,22,23,24]. However, the utility of these computa-
tional methods is limited because they lack systematic validation
and tend to be computationally expensive, which poses a barrier
for practical applications in influenza surveillance.
Here, we report a novel computational method that uses an
effective scoring function to quantify the binding strength of HA-
receptor interactions with high accuracy and speed. We
demonstrate the utility of this method, with a focused large-scale
sequencing and experimental verification, in identifying molecular
events that underlie the receptor specificity changes during the
evolution of human H3N2 Fujian-like viruses.
Results
A rapid computational method for predicting
HA-receptor binding activity
The binding of an influenza virus to a host cell can be
approximated by the interaction between HA and the host
receptor analog, sialyloligosaccharides [25]. In this study, the a2–3
pentasaccharide (LSTa, Neu5Aca(2–3)Galb(1–3)GlcNAcb(1–
3)Galb(1–4)Glc) and a2–6 pentasaccharide (LSTc, Neu5Aca(2–
6)Galb(1–4)GlcNAcb(1–3)Galb(1–4)Glc) were used for avian and
human receptor analogs, respectively. Previously, Xu et al found
that when binding to HAs, the pentasccharide receptor analogs,
seemingly quite flexible, exhibit limited binding modes [23]. We
also found that binding positions of the receptor analogs relative to
HAs are highly conserved and the backbone conformation at
receptor binding region is almost fixed, when analyzing the co-
crystal structures involving HAs from different type A viruses.
Therefore, to propose a computational framework to rapidly
estimate the binding strength of HA and the receptor analogs, we
used the predominant topologies of cone-like and umbrella-like
ones to represent avian and human host receptor analog
structures, respectively [26], and further fixed their relative
binding positions as observed in the co-crystal structures involving
the same subtype of HA (see Materials and Methods). Such an
approximation allows us to identify the comparative impacts of
different HA sequences on receptor binding while keeping other
factors consistent. Our computational method consists of four steps
(details see Materials and Methods). First, for an HA of interest, its
structure was constructed based on homology modelling using an
available HA crystal structure that is highly similar to the target
HA (.70% sequence identity). Second, the HA structure was
aligned against known HA-receptor complex templates and the
binding position of the receptor analog in the HA receptor binding
domain was initialized. Third, the conformations of side chains at
receptor binding sites were refined. Fourth, the binding strength of
HA and receptor analog was evaluated by an effective empirical
scoring function developed in this study (see below). The
computations took less than 2 minutes on an Intel Xeon
2.8 GHz processor, much less computationally demanding than
traditional molecular dynamics techniques that usually took weeks
for binding free energy calculations. Thus, the approach
developed here can be used in large-scale applications such as
the rapid monitoring of evolution of influenza receptor binding
specificities.
An effective scoring function for evaluating HA-receptor
binding strength
The critical step in our computational method was to develop a
scoring function that can quantify the binding strength between an
HA and avian/human receptor anlog. To this end, we developed
an empirical scoring function by taking into account the effect of
electrostatics (Eec) and shape complementarity (Esc) on HA-
receptor binding, described as below:
Ebind~w1Eeczw2Esc ð1Þ
where the w1 and w2 are the weights. The electrostatic interaction
term, Eec, uses the inter-molecular Coulomb term:
Eec~
X
HA
X
receptor
332
qiqj
edij
ð2Þ
where dij is the distance of HA atom i and receptor atom j. And the
qi and qj are the atom charges. e is the dielectric constant which is
set to be 1.
Shape complementarity is a geometric descriptor for delineating
the geometric match at the binding interface between interacting
molecules. Usually it is based on either molecular surface
curvatures or surface areas. Here, we propose a curvature
weighted surface area model to calculate the shape complemen-
tarity term, Esc. We first follow the classic method of Connolly ML
[27] to quantify the surface curvature by using a probe sphere
centering at the solvent accessible surface (S) and calculating the
ratio of sphere volume out of the solvent accessible surface (Vout) to
its total volume (Vsphere). Then, a shape score Eshape is calculated
by integrating the surface curvature over the solvent accessible
surface S:
Eshape~{
ðð
S
log(
Vout
Vsphere
)ds ð3Þ
In this formula, a logarithm operation is introduced to enhance
the sensitivity to cavities on surface. Finally, the shape comple-
mentarity term Esc considers the buried shape score as a result of
binding, which is calculated as follows:
Esc~E
HA
shapezE
receptor
shape {E
complex
shape ð4Þ
Since our scoring function can be generalized to score other
molecular interactions, we first trained to fit the predicted binding
scores to the measured on PDBbind database [28], a set of protein-
ligand complexes with crystal structures and experimentally
determined Ki and Kd values. In the training, we attempted to
obtain highest Pearson’s correlation coefficients between the
predicted binding scores and the measured Ki or Kd values. We
found it has a desirable performance (see Table S1), which is
comparable to the best existing scoring functions of same kind (see
Table S2). To further improve its performance in the prediction of
HA-receptor binding activity, the equation (1) was retrained on the
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experimental data consisting of apparent association constants for
binding of 21 HAs with avian/human receptor analogs [12] (See
Table S2). For each of the 21 HAs, we calculated the differed
values of electrostatic term and shape complementarity term
between a2–6 receptor and a2–3 receptor:
w1 E
a2{6
ec {E
a2{3
ec
 
zw2 E
a2{6
sc {E
a2{3
sc
 
~ log
Ka2{6ass
Ka2{3ass
 
ð5Þ
The parameters w1 and w2 were obtained by linear regression
analysis of the above equation using least squares. The calculated
binding scores have a relatively good correlation with the
experimental data (w1 =20.05 and w2 = 0.057, Pearson’s correla-
tion coefficient = 0.67, P value = 0.0009, and standard deviation
= 0.90). Based on this training method, DEa2{6bind {DE
a2{3
bind ~1:0
represents about 10 times more binding preference for human
receptor than for avian receptor.
Predicted critical mutations on HAs correlate with
experimental measurements
Recent efforts on characterizing the effects of amino acid
mutations on HA-receptor binding specificity have provided
experimental data with which we can assess the performance of
our computational method. The amino acid substitutions that
were experimentally identified to change the binding strength to
either avian or human receptor, especially the receptor preference
were regarded as critical mutations. Several well-characterized
critical mutations for HAs of H1N1, H3N2 and H5N1 viruses
were collected from literature (Table S3). To validate whether our
predictions are consistent with the experimental observations, for
each of these mutations, the receptor binding strength for the
interactions of HA with avian and human receptors were
computed both for the wild type and mutated HA to yield the
change DEbind :
DEbind~E
MUT
bind {E
WT
bind ð6Þ
To achieve a best correlation with the experimental data, a
single mutation on HA that causes a change in binding strength
with an absolute value of DEbind $1.0 when binding to either
avian or human receptor was regarded as a predicted critical
mutation (#21.0: decreased binding activity (Q), and $1.0:
increased binding activity (q)) (Table S3). Based on these criteria,
our method successfully predicted the well studied critical
mutations that are responsible for receptor binding activities,
including residue 190 and 225 (H3 numbering) for H1N1 [29],
residue 226 and 228 for H3 subtypes [30,31] and residue 186 and
196 (H3 numbering) for H5N1 [17]. Overall, 19 of 22 (,86%)
predicted critical mutations matched those observed in experi-
ments, demonstrating the reliability of our method in quantifying
effect of HA mutations on their binding to avian/human
receptors.
Predicted receptor binding preferences of influenza A
viruses correlate with host origins
Next, we determined whether the computational method was
able to discriminate between avian viruses and human viruses
based on the predicted receptor binding preferences. For this
purpose, we collected all the H1 and H3 avian and human viruses
and the avian H5N1 viruses including those infected humans up to
2008 from the NCBI Influenza Virus Resource. After removing
the redundant sequences, 193 human H1N1 viruses, 75 avian
H1N1 viruses, 360 human H3N2 viruses, 152 avian H3N2 viruses,
686 avian H5N1 viruses and 144 human-infecting H5N1 viruses
were selected (see Methods S1). Given that the human and avian
receptor analogs may not represent their respective actual
receptors equally well, we did not directly compare their calculated
binding strengths to the same HA. To compare their binding
preference, we used a receptor binding preference index, which
was quantified as the difference between the binding strengths for
the human receptor and that for the avian receptor
(Ea2{6bind {E
a2{3
bind ). A larger value indicates a greater preference
for human receptors and vice versa. In the case of H3N2 viruses,
the average receptor binding preference index for avian H3N2
viruses is 21.5, considerably smaller than that for human H3N2
viruses, which is 5.2. Fig. 1A shows that the distribution of avian
and human H3N2 HAs according to the predicted receptor
binding preference index. At a cut-off of 0.0,86.7% human H3N2
viruses and 94.1% avian H3N2 viruses show their natural receptor
preferences respectively. Fig. 1C shows that the computational
method also distinguished human and avian H1N1 viruses based
on the predicted receptor binding preference index: the average
value for avian viruses is 9.5, much smaller than 15.2 for human
viruses. At a cut-off of 12.0,86.5% human and 100% avian viruses
show their host receptor preferences respectively.
We quantified the performance of the computational prediction
by constructing receiver-operator characteristic (ROC) curves. In
ROC curves, the true positive rate (Y-axis) was plotted as a
function of the false positive rate (X-axis) for different cut-off
values, and thus the closer is the curve to upper left corner, the
better the prediction performance is. As shown in Fig. 1B and 1D,
the ROC plots of both H3 and H1 tests are close to the upper left
corner, indicating that the computational method is effective in
distinguishing avian and human viruses based on their HA
receptor binding strengths. These analyses show that predicted
receptor binding preferences are highly correlated with the host
specificities of natural influenza A viruses.
In the case of H5N1 viruses, although avian H5N1 viruses have
started to infect humans sporadically, the human-infecting H5N1
viruses have not been adapted to humans and cannot be efficiently
transmitted between humans, indicating their binding specificities
have not been changed. Notably, in our calculation, we also found
human-infecting H5N1 viruses and other avian H5N1 viruses are
indistinguishable in the predicted receptor binding specificities
(Fig. S1A, S1B), which is consistent with the fact that the human-
infecting H5N1 viruses have not been adapted to humans. This
suggests that our calculation is valid.
Application of the computational method to track the
evolution of receptor binding specificities of human
H3N2 viruses
To test the value of the computational method for influenza
surveillance, we determined the molecular events underlying
receptor specificity changes in the evolution of the Fujian-like
(H3N2) viruses by combining the binding strength predictions with
large-scale HA sequencing. HA genes from a total of 207 human
H3N2 viruses isolated from diverse regions in China between 2000
and 2002 were sequenced. Based on these sequences, phylogenetic
analyses of these H3N2 HAs revealed two temporally distinct
clades that we designate as Panama and Fujian, after the WHO-
recommended vaccine strains of the A/Panama/2007/99 and A/
Fujian/411/02 viruses (Fig. 2 and Fig. S2). The Fujian clade
appeared in China in the 2002–2003 flu season, one season earlier
than in the United States (Fig. S2A, S2B). To gain molecular
insights into the evolution of the Fujian clade, we further tracked
Predicting Influenza HA-Receptor Binding Activity
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the detailed amino acid changes along the phylogenetic tree
(Fig. 2B). As shown in Fig. 2B, the focused sequencing effort
uncovered remarkable sequence diversity present in the HA1
subunit, allowing a visual representation of almost all amino acid
substitution intermediates between the Panama-like viruses and
the Fujian-like viruses over time.
To uncover the receptor binding changes during the evolution
of the Fujian-like viruses, the binding strengths of HA to both the
human and avian receptor analogs were calculated for each of the
207 virus isolates. Fig. 2C shows the dynamic change of binding
strength of HA to both the human and avian receptor analogs
during evolution by tracking the binding strengths for each HA on
the phylogenetic tree (Fig. 2A). It is noticeable that the decrease in
binding strengths for both the avian receptor and human receptor
occurred twice during the evolution of Fujian-like viruses from
Panama-like viruses: the first one occurred at the beginning of the
2001–2002 flu season and the second one at the beginning of the
2002–2003 flu season. A side-by-side, visual comparison of amino
acid changes (Fig. 2B) and receptor binding changes (Fig. 2C)
allows association of specific amino acid change(s) with alterations
in receptor binding properties. For example, the mutations of
W222R and G225D located at the receptor binding region took
place at the beginning of the 2001–2002 flu season, when
predicted binding strength decreased. By modelling the effect on
receptor binding of each mutation at all thirteen sites that differed
between A/Panama/2007/99 and A/Fujian/411/02 viruses (Fig.
S3 and Fig. S4), we found that the mutations at residues 222 and
225 played the most important role in mediating receptor binding
alterations in the Fujian-like viruses (The detailed analysis is given
in the legends of Fig. S3).
Experimental validation of the predicted molecular
mechanism
To test whether the amino acid changes at residues 222 and 225
considerably changed HA’s receptor binding specificity, we mutated
the residues 222 and 225 in HA of A/Fujian/411/02 virus back to
the corresponding residues of HA of A/Panama/2007/99 viruses
and measured binding of the double mutant and two wildtype HAs
with either a2–3 or a2–6 linked sialic acid receptors by a
hemadsorption assay (see Methods S1). In agreement with
prediction, the wild type A/Fujian/411/02 HA exhibited a
considerably weaker binding to both a2–3 and a2–6 receptors
than the wildtype A/Panama/2007/99 HA (Fig. 3, p,0.05). When
residues 222 and 225 in A/Fujian/411/02 HA were mutated to the
corresponding residues of A/Panama/2007/99 HA, the resulting
HA had a considerable increase in binding activity to both a2–3 and
a2–6 receptors. These results confirm the prediction, showing that
Figure 1. Predicting receptor binding preferences of natural H1, H3 and H5 viruses. A, C, The distribution of H3 (A) H1 (C) viruses isolated
in humans and avian species according to their receptor binding preference indices are defined as the difference of binding score to the human and
avian receptor analogs (Ea2{6bind {E
a2{3
bind ). E
a2{3
bind and E
a2{6
bind indicate the predicted binding strength of HA with the avian receptor analog LSTa) and the
human receptor analog (LSTc), respectively. B, D, Receiver-operator characteristic (ROC) curves of predicting human/avian H3 viruses (B), human/
avian H1 viruses (D). The ROC curves are plotted as rate of true positives as a function of rate of false positives at different values of Ea2{6bind {E
a2{3
bind .
doi:10.1371/journal.pone.0018664.g001
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the changes in HA residues 222 (W to R) and 225 (G to D) indeed
caused a considerably low receptor binding activity for a2–3 sialic
acid receptor during the evolution of Fujian-like viruses.
Discussion
Here, we report a novel computational method for measuring
interaction strength between influenza HA and their host cell
receptors. This method can predict binding strengths of a wide
variety of influenza HA, and was rigorously tested for accuracy.
Application of this computational method has enabled us to
identify how receptor specificities change during the evolution of
human H3N2 Fujian-like viruses. We predicted and further
validated by experimentation that W222R and G225D mutations
in HA result in a change in receptor binding specificity during the
evolution of the Fujian-like viruses.
The computational method employs an effective scoring
function which translates both sequence and structural informa-
tion of HA into quantitative HA-receptor binding strength by
evaluating the effects of electrostatic and shape complementarity.
These two physical features have been widely used in studying
protein-ligand interactions. They enable us to identify how
binding strengths change with aspect to the amino acid changes.
In this study, they are used to identify the critical mutations,
changes in viral host-specificity, and binding activity changes
during the course of virus evolution.
One major difficulty in computational modelling of HA-
receptor binding is accurate representation of the receptors.
Figure 2. Evolution of receptor binding specificity of the Panama- and Fujian-like viruses. A, Phylogenetic analysis of evolutionary history
of human H3N2 viruses isolated in China from year 2000 to 2002 covering flu seasons from 1999–2000 to 2002–2003. The red stars denote the
position of A/Panama/2007/1999 virus and A/Fujian/411/2002 virus on the phylogenetic tree. Key amino acid changes are shown at the indicted
positions during the evolution from Panama-like viruses to Fujian-like viruses. B, Dynamic changes of amino acids at 13 sites that differ between
Panama-like viruses and Fujian-like viruses alined along the phylogenetic tree in A. Color code of amino acids, represented by a single letter, is shown.
‘X’ and ‘-‘ indicates unknown amino acid and gaps, respectively in the HA sequence. C, Comparison of calculated binding strengths for all HAs in A to
both avian (a2–3) and human (a2–6) receptor analogs, normalized to those of HA of A/Panama/2001/99 by
Ebind{Ebind panama
Ebind panama
. The heat map of
binding strength is aligned with the corresponding HAs in the phylogenetic tree to indicate dynamic change of the binding strengths of these viral
HAs to both avian and human receptors during evolution. Scale of normalized binding strength values is shown. From year 1999 to 2003, cool colours
changed to be hot colours. It reflects the binding strength was decreased, especially for the avian receptor analog. The red stars denote the
normalized binding strength values of A/Panama/2007/1999 virus and A/Fujian/411/2002 virus.
doi:10.1371/journal.pone.0018664.g002
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Although sialyltrisaccharides or sialyldisaccharides were used in
previous modelling [18,19,21,22,32], recent studies show that the
human receptor moiety beyond the third glycan also interacts with
HAs and plays a role in virus binding to human receptors [33]. In
our study, we also used the shorter sialyltrisaccharide glycans and
found that they did not discriminate receptor-binding specificity
between avian and human influenza A viruses as well as the longer
sialylpentasaccharide glycans. Thus, we used sialylpentasaccharide
glycans in all the analyses. Although more accurate, the
pentasaccharide receptor is still a simple representation of the
physiological receptors and the prediction of receptor specificity of
influenza virus is not straightforward. It is difficult to determine
whether a virus binds preferentially to human or avian receptors
by directly comparing its binding scores to the two different
receptor ligands. To circumvent this problem, we interpret the
binding strength or specificity comparatively among different HAs
or compare relative binding strength or specificity to a reference
HA. This interpretation can cancel out, to some degree, the
unknown effects of various factors in comparison.
Accurate and timely monitoring of the evolution of HA’s
receptor specificity is critical for global preparedness for influenza
epidemics and pandemics. Since their introduction into humans,
the receptor-binding specificity of human H3N2 viruses has
changed continuously [12,34,35,36,37,38]. The 2003–2004 flu
season was especially severe, because an effective vaccine against
the highly virulent H3N2 Fujian-like strains was not available in
time due to the poor growth of the Fujian-like virus in
embryonated chicken eggs. Several groups have investigated the
molecular basis underlying the poor replication of the Fujian-like
viruses in embryonated chicken eggs. Using reverse genetics, Lu et
al. found that the unbalanced HA receptor-binding activity and
NA enzymatic activity in the Fujian virus contributes to its poor
growth in embryonated chicken eggs. Better virus growth can be
achieved by either increasing the HA receptor-binding activity via
G186V and V226I mutations in HA or lowering the NA
enzymatic activity via E119Q and Q136K mutations in NA [4].
By passaging the Fujian-like viruses in chicken eggs, it was found
that mutations in HA not in NA improve the replication of the
virus in chicken eggs and these mutations also increase HA
binding activities to the avian receptors. Three different pairs of
mutations, including G186V and V226I, H183L and V226A, or
H183L and D188Y, have been identified in egg-adaptation of
Fujian virus [4,39,40]. However, these mutations are unlikely to
mediate the evolution of Fujian-like viruses in nature since none of
them occurred in either Fujian clade or Panama clade.
By large scale sequencing of HAs of human H3N2 viruses
sampled from different regions in China during 2000-2002 and
computational modelling, we were able to trace the molecular
events and characterize the evolutionary dynamics of receptor
specificity changes in the evolution of Fujian-like viruses. We
predicted that W222R and G225D mutations in HA result in a
decreased binding activity to both human and avian receptors,
particularly to avian receptors, during the evolution of the Fujian-
like viruses. To test whether the decreased HA-receptor binding
activity was accompanied by a decrease in viral infectivity in
chicken eggs when the residues 222 and 225 were changed in the
Panama clade, we compared the replication efficiency in chicken
eggs of the viruses bearing different amino acids at residues 222
and 225 within the same antigenic Panama clade (see Methods
S1). Wild type A/Panama/2007/99 viruses bearing 222W and
225G in HA replicated efficiently in chicken eggs, while the A/
Panama/2007/99 viruses with a single mutation (222W or 225D)
or double mutations (222R and 225D) replicated poorly (Fig. S5A,
p = 0.0009; Fig. S5B, p = 0.057). The correlation between the
decreased HA’s receptor-binding activity and the poor viral
growth in the chicken eggs suggests that the amino acid changes at
residues 222 and 225 contribute to the poor replication of the
wildtype A/Fujian/411/02 virus in chicken eggs.
Studies have shown that H155T and Q156H substitutions in
HA were sufficient to render the Panama virus antigenically
equivalent to A/Wyoming/03/03, an A/Fujian/411/02-like
H3N2 virus [5]. By showing that W222R and G225D substitutions
in HA mediate receptor specificity changes, we uncovered the
evolutionary relationship between receptor specificity and antige-
nicity in the evolution of Fujian-like viruses. While antigenicity
changes at residues 155 and 156 occurred in the 2002–2003 flu
season, changes that impacted on receptor binding occurred over
a year earlier at the beginning of the 2000–2001 flu season (Fig. 2A
and 2C). It can be envisioned that such findings are of critical
importance for global influenza surveillance as they can alert us
earlier to prepare for changes in receptor-binding specificity and
an imminent influenza epidemic or pandemic. Our approach can
provide an urgently needed tool for rapid and large-scale analysis
of HA receptor specificities for global influenza surveillance.
Materials and Methods
Computational method for predicting HA-receptor
binding strength
Structure templates for HA-receptor complexes were obtained
from Protein Data Bank(PDB) [41]. The HA moiety of 1RVX of
H1N1 virus, 1MQN of H3N2 virus, and 2IBX of H5N1 virus
were used as HA templates for their respective virus subtypes.
Protein atom charges are obtained from CHARMM22 [42]. The
avian and human receptor analogs were LSTa (Neu5Aca(2–
3)Galb(1–3)GlcNAcb(1–3)Galb(1–4)Glc) and LSTc (Neu5Aca(2–
6)Galb(1–4)GlcNAcb(1–3)Galb(1–4)Glc), respectively. As the com-
plete structure of LSTa in complex with HA is not available, its
coordinates were prepared from 2RFT and the glycosidic torsion
Figure 3. Experimental validation of amino acid residues
critical for altered receptor-binding specificity of Fujian-like
viruses. Comparison of receptor binding activities of wild type Panama
and Fujian HAs and Fujian HA with R222W and D225G mutations
(FjR222W/D225G). Briefly, the wild type and mutant HAs were
expressed on the surface of 293T cells. Sialic acid was removed from
chicken red blood cells with neuraminidase and resialylated to express
either a2–3 or a2–6 linked sialic acid. The amount of red blood cells
bound to HA expressed on the 293T cell surface was measured by
absorbance at 540 nm. GFP-transfected 293T cells were used as a
control for nonspecific binding. Representative data from one of the
five experiments are shown. *p,0.05.
doi:10.1371/journal.pone.0018664.g003
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angles were reset referring the modelling data by Xu et al. [23].
The coordinates of LSTc were extracted directly from 1RVT and
1JSI. Hydrogen atoms and charges were generated by the Dundee
PRODRG2 Server [43].
The computational method to calculate HA-receptor binding
strength consists of four steps. In step 1, the structure of the target
HA sequence is built. The HA sequence is first aligned to the
template HA of same subtype virus by CLUSTALW [44], then is
threaded to the template, and finally the conformations of its side
chains are modeled by a fast side chain construction program,
SCWRL4 [45]. Any site with a gap or insertion is automatically
ignored. In step 2, the receptor analog is transferred to the newly
built HA in the same position as that relative to template HA in
the template. Its coordinates were manually adjusted to avoid
steric clashes with HA templates. In step 3, the amino acid side
chains which contain atoms within a 12 A˚ distance from the
receptor analog are repacked using a heuristic iteration search
algorithm to optimize side chain conformations sequentially [46]
based on an empirical scoring function parameterized over known
HA structures (see Methods S1). This scoring function contains
van der Waals, salt bridge and solvation effects. The side chain
conformations use the Dunbrack rotamer library [47]. In step 4,
protein hydrogen atoms are added according to their standard
coordinates data from CHARMM22 [42]. Then HA-receptor
binding strength is calculated according to a scoring function
developed in our study (see text).
The software developed from the current study is free for non-
commercial users at web site: http://jianglab.ibp.ac.cn/lims/
harbp/harbp.html.
Sequencing and sequence analysis
HA sequences used in this analysis were generated at the
Chinese Influenza Center as part of an ongoing routine genetic
analysis of HA genes of variant and typical influenza field strains.
See Methods S1 for details.
Hemadsorption glycan-binding assay
The hemadsorption glycan-binding assay protocol was modified
from Glaser et al. [29]. See Methods S1 for details.
Supporting Information
Figure S1 Predicting receptor binding preferences of
natural H5 viruses, related to Figure 1. A, The distribution
of H5 viruses isolated in humans and avian species according to
their receptor binding preference indices are defined as the
difference of binding score to the human and avian receptor
analogs (Ea2{6bind {E
a2{3
bind ).E
a2{3
bind and E
a2{6
bind indicate the predicted
binding strength of HA with the avian receptor analog LSTa) and
the human receptor analog (LSTc), respectively. B, Receiver-
operator characteristic (ROC) curves of predicting human-
infecting/avian H5 viruses. The ROC curves are plotted as rate
of true positives as a function of rate of false positives at different
values of Ea2{6bind {E
a2{3
bind .
(TIF)
Figure S2 Tracking the evolution of receptor binding
specificities of human H3N2 viruses, related to Figure 2.
(A-B) Phylogenetic analyses of the evolutionary histories of human
H3N2 viruses isolated in China (A) and the USA (B) from 1999 to
2003. Phylogenetic tree analyses of 207 viruses isolated in China
and 370 viruses isolated in USA from year 2000 to 2003 (covering
flu seasons, 1999–2000, 2000–2001, 2001–2002 2002–2003, and
2003–2004). Color code of amino acids, represented by a single
letter, is shown. ‘X’ and ‘–’ indicate unknown amino acids and
gaps, respectively, in the sequences. Note: The amino acid changes
usually occur in viruses isolated in China earlier than those
isolated in the USA. H155T, Q156H, W222R and G225D
indicate key mutational events in the evolution of the Panama
clade to Fujian clade.
(TIF)
Figure S3 Computational identification of amino acid
residues critical for altered receptor-binding specific-
ity of Fujian-like viruses, related to Figure 2. A: 13
different residues (red) between Panama and Fujian viruses on the
structure of HA1. The binding region is highlighted by a yellow
circle. B and C, Comparison of calculated binding strength of
wildtype Panama (Pn) and Fujian (Fj) HAs to avian (a2–3) (b) and
human (a2–6) (c) receptor analogs with specific amino acid
changes in the HAs. To pinpoint the molecular changes
responsible for the receptor specificity changes in A/Fujian/
411/02, we modeled the effect on receptor binding of each
mutation at all thirteen sites that differed between A/Panama/
2007/99 and A/Fujian/411/02 viruses. For binding to the a2–3
sialic acid receptor (B), most single amino acid changes on the A/
Panama/2007/99 HA did not have much effect except for
changes at four residues, 155, 186, 222 and 225, which resulted in
significant decreases in binding strength compared to the wild
type. When positions 222 and 225 were changed simultaneously,
the binding strength was further decreased. For single amino acid
changes on the A/Fujian/411/02 HA backbone, only two changes
at residues 222 and 225 resulted in a significant increase in binding
strength compared to the wildtype. Similarly, simultaneous
changes at positions 222 and 225 resulted in further decrease in
binding strength. For binding to the a2–6 sialic acid receptor (C),
residue 222 and 225 stood out again in that change at this position
in HA of A/Panama/2007/99 and A/Fujian/411/02 viruses
exhibited the reciprocal effect. These calculations suggest that the
mutations at residues 222 and 225, which occurred at the
beginning of the 2000–2001 flu season, played the most important
role in mediating receptor binding alterations in the Fujian-like
viruses.
(TIF)
Figure S4 HA1 sequence alignment of Panama and
Fujian virus. The 13 different residues are highlighted by the
blue color. Receptor binding region comprises the 130-loop (134–
142, H3 numbering), 150-loop (150–156), 190-helix (181–193) and
220-loop (220–230) (Yellow background).
(TIF)
Figure S5 Comparison of growth of the Panama virus
(222W/225G) and its variants 222W/225D and 222R/
225D in embryonated chicken eggs, related to Figure 3.
A: Quantification by quantitative RT-PCR. The relative RNA
copy is the ratio of the RNA copies in the embryonated chicken
eggs after viral infection of 44 hours to those in the embryonated
chicken eggs infected with same amount of viruses but kept frozen
for 44 hours. (*p = 0.0009). B: Quantification by HA assay. The
values of HA titers are average of either seven 222W/225G
isolates, two 222W/225D isolates, or five 222R/225D isolates.
(*p = 0.057)
(TIF)
Table S1 Comparison with popular scoring functions
on PDBbind database.
(DOC)
Table S2 Training data for the scoring function.
(DOC)
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Table S3 Validation of the computational method using
well characterized mutations.
(DOC)
Methods S1 Supporting methods.
(DOC)
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